Literature DB >> 12498283

Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Christoph Herold1, Sabine Regn, Marion Ganslmayer, Matthias Ocker, Eckhart G Hahn, Detlef Schuppan.   

Abstract

Studies comparing quantitative testing of liver function (QTLF) in large numbers of patients with defined etiology of cirrhosis are lacking. In all 316 patients with proven cirrhosis underwent QTLF, including aminopyrine breath test (ABT), galactose elimination capacity (GEC), sorbitol (SCI), and indocyanine green clearance (ICG). Values were correlated with the Child-Pugh classification (CP) and the etiology of liver cirrhosis. Fifty-five percent of the patients had alcoholic cirrhosis (ALC), 31% cirrhosis due to viral hepatitis (VIC), and 14% primary biliary cirrhosis (PBC). In all three groups there was a decrease of QTLF levels from CP grade A to C, which differed from normal values. QTLF was most compromised in patients with ALC and VIC compared to patients with PBC. In conclusion, QTLF in ALC and VIC patients was more reduced than in patients with PBC. This may be due to saturation of enzymes in ALC and ongoing inflammation in VIC.

Entities:  

Mesh:

Year:  2002        PMID: 12498283     DOI: 10.1023/a:1021088618300

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.

Authors:  J Zeeh; H Lange; J Bosch; S Pohl; H Loesgen; R Eggers; M Navasa; J Chesta; J Bircher
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

2.  Prognostic evaluation in alcoholic cirrhosis.

Authors:  N Tygstrup; P K Andersen; B L Thomsen
Journal:  Acta Med Scand Suppl       Date:  1985

Review 3.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

4.  The 30-minute aminopyrine breath test: optimization of sampling times after intravenous administration of 14C-aminopyrine.

Authors:  T Miotti; J Bircher; R Preisig
Journal:  Digestion       Date:  1988       Impact factor: 3.216

5.  Hepatic parenchymal cell volume and the indocyanine green tolerance test.

Authors:  M Hashimoto; G Watanabe
Journal:  J Surg Res       Date:  2000-08       Impact factor: 2.192

6.  Assessment of lidocaine metabolite formation in comparison with other quantitative liver function tests.

Authors:  B Meyer-Wyss; E Renner; H Luo; A Scholer
Journal:  J Hepatol       Date:  1993-08       Impact factor: 25.083

7.  Combined evaluation of total and functional liver plasma flows and intrahepatic shunting.

Authors:  G Molino; P Avagnina; M Ballarè; M Torchio; A G Niro; P E Aurucci; M Grosso; C Fava
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

8.  Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.

Authors:  C Merkel; M Bolognesi; G F Finucci; P Angeli; L Caregaro; M Rondana; A Gatta
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

9.  Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein.

Authors:  Y Horsmans; D Lejeune; A P Geubel; J B Otte; S Pauwels
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

10.  Non-invasive evaluation of portal-systemic shunting in man by D-sorbitol bioavailability.

Authors:  A Cavanna; G Molino; M Ballarè; M Torchio; M Fracchia; P Avagnina; J Bircher
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

View more
  4 in total

1.  Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease.

Authors:  Aksel Lange; Henning Grønbæk; Hendrik Vilstrup; Susanne Keiding
Journal:  Scand J Gastroenterol       Date:  2010-11-01       Impact factor: 2.423

2.  Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.

Authors:  Nariné Baririan; Luc Van Obbergh; Jean-Pierre Desager; Roger K Verbeeck; Pierre Wallemacq; Peter Starkel; Yves Horsmans
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy.

Authors:  Matthias Ocker; Marion Ganslmayer; Steffen Zopf; Susanne Gahr; Christopher Janson; Eckhart-G Hahn; Christoph Herold
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

4.  Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.

Authors:  M Miller; A Kahraman; B Ross; M Beste; Guido Gerken
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.